Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finke

Showing results (191-200 of 270) with videos related to

Pageof 27
Sort By:
Cancer Research|November 15, 1989
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effectsG T Budd, B Osgood, B Barna, et al.
Epidemiology and Infection|May 3, 2006
A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004S Essbauer, J Schmidt, F J Conraths, et al.
Leukemia & Lymphoma|May 20, 2022
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicinT Strüßmann, R Wäsch, F Scherer, et al.
Journal of Medical Microbiology|December 17, 2008
An outbreak of oropharyngeal tularaemia linked to natural spring waterA Willke, M Meric, R Grunow, et al.
Bone Marrow Transplantation|July 9, 2021
Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2003
Influenza pandemic: preparedness planning in GermanyR Fock, H Bergmann, H Bussmann, et al.
Blood|December 1, 1995
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrowD von Laer, U Meyer-Koenig, A Serr, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 4, 1993
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effectsR M Bukowski, S Murthy, D McLain, et al.
Epidemiology and Infection|February 20, 2007
Re-emergence of Francisella tularensis in Germany: fatal tularaemia in a colony of semi-free-living marmosets (Callithrix jacchus)W D Splettstoesser, K Mätz-Rensing, E Seibold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.
Pageof 27

Showing results (191-200 of 270) with videos related to

Sort By:
Pageof 27
Cancer Research|November 15, 1989
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effectsG T Budd, B Osgood, B Barna, et al.
Epidemiology and Infection|May 3, 2006
A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004S Essbauer, J Schmidt, F J Conraths, et al.
Leukemia & Lymphoma|May 20, 2022
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicinT Strüßmann, R Wäsch, F Scherer, et al.
Journal of Medical Microbiology|December 17, 2008
An outbreak of oropharyngeal tularaemia linked to natural spring waterA Willke, M Meric, R Grunow, et al.
Bone Marrow Transplantation|July 9, 2021
Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemiaC Greil, M Engelhardt, G Ihorst, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2003
Influenza pandemic: preparedness planning in GermanyR Fock, H Bergmann, H Bussmann, et al.
Blood|December 1, 1995
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrowD von Laer, U Meyer-Koenig, A Serr, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 4, 1993
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effectsR M Bukowski, S Murthy, D McLain, et al.
Epidemiology and Infection|February 20, 2007
Re-emergence of Francisella tularensis in Germany: fatal tularaemia in a colony of semi-free-living marmosets (Callithrix jacchus)W D Splettstoesser, K Mätz-Rensing, E Seibold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.
Pageof 27